Hydrochlorothiazide/triamterene
| Combination of | |
|---|---|
| Hydrochlorothiazide | Thiazide diuretic |
| Triamterene | Potassium-sparing diuretic |
| Clinical data | |
| Trade names | Dyazide, Maxzide, others |
| Other names | co-triamterzide |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Hydrochlorothiazide/triamterene, also known as co-triamterzide, is a fixed-dose combination medication of hydrochlorothiazide and triamterene.[2] [3] [4] It is used to treat high blood pressure and edema (swelling).[2] [3] [4] Specifically it is used in those who develop low blood potassium (hypokalemia) when on only hydrochlorothiazide.[2] [3] It is taken by mouth.[2] [3] [4]
Side effects may include nausea, trouble sleeping, dizziness, feeling light headed with standing, kidney problems, allergies, and muscle cramps.[2] [3] Other serious side effects may include high blood potassium.[2] [3] Use in pregnancy and breastfeeding is not generally recommended.[2] [3] Use in those with significant kidney problems is not recommended.[2] [3] It decreases blood pressure mainly by hydrochlorothiazide while triamterene decreases the amount of potassium lost.[2] [3]
The combination was approved for medical use in the United States in 1965.[5] In 2022, it was the 116th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[6] [7]
References
[edit ]- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA . Retrieved 22 October 2023.
- ^ a b c d e f g h i j "Dyazide- hydrochlorothiazide and triamterene capsule". DailyMed. 31 October 2017. Retrieved 20 August 2020.
- ^ a b c d e f g h i j "Maxzide-25- maxzide tablet Maxzide tablet". DailyMed. 20 July 2018. Retrieved 20 August 2020.
- ^ a b c British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 76. ISBN 9780857113382.
- ^ "Dyazide: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 20 August 2020.
- ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- ^ "Hydrochlorothiazide; Triamterene Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.